| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.848 | 0.001 | 0.848 | Dihydrofolate reductase inhibitor | 0.72 0.001 DBMET02314 0.686 0.001 DB00116 0.188 0.002 DBMET02316 0.396 0.002 DBMET00528 | ||
| 0.535 | 0.002 | 0.535 | Folate antagonist | 0.307 0.003 DBMET02314 0.348 0.003 DB00116 0.25 0.005 DBMET02316 0.342 0.003 DBMET00528 0.176 0.015 DBMET00506 | ||
| 0.518 | 0.012 | 0.518 | DNA synthesis inhibitor | 0.371 0.026 DBMET02314 0.445 0.017 DB00116 0.344 0.031 DBMET02316 0.488 0.014 DBMET00528 0.389 0.023 DBMET00506 | ||
| 0.491 | 0.001 | 0.527 | Thymidylate synthase inhibitor | 0.427 0.001 DBMET02314 0.527 0.001 DB00116 0.219 0.002 DBMET02316 0.43 0.001 DBMET00528 0.084 0.006 DBMET00506 | DB00116 | |
| 0.454 | 0.001 | 0.454 | Dihydropteroate synthase inhibitor | 0.234 0.002 DBMET02314 0.185 0.003 DB00116 0.155 0.003 DBMET00528 | ||
| 0.437 | 0 | 0.437 | AICAR transformylase inhibitor | 0.305 0.001 DBMET02314 0.418 0.001 DB00116 0.071 0.009 DBMET02316 0.351 0.001 DBMET00528 0.056 0.017 DBMET00506 | ||
| 0.428 | 0.003 | 0.428 | Antimetabolite | 0.225 0.008 DBMET02314 0.203 0.009 DB00116 0.1 0.016 DBMET02316 0.235 0.008 DBMET00528 0.137 0.013 DBMET00506 | ||
| 0.37 | 0.053 | 0.521 | Immunomodulator | 0.269 0.101 DB00116 0.413 0.04 DBMET00528 0.521 0.02 DBMET00506 | DBMET00506 | |
| 0.299 | 0.005 | 0.353 | Hematopoietic | 0.151 0.015 DBMET02314 0.249 0.006 DB00116 0.105 0.031 DBMET02316 0.353 0.005 DBMET00528 0.255 0.006 DBMET00506 | DBMET00528 | |
| 0.329 | 0.056 | 0.4 | Interleukin 2 agonist | 0.326 0.057 DBMET02314 0.344 0.048 DB00116 0.301 0.073 DBMET02316 0.343 0.049 DBMET00528 0.4 0.027 DBMET00506 | DBMET00506 | |
| 0.332 | 0.07 | 0.534 | Immunostimulant | 0.194 0.124 DBMET02314 0.306 0.077 DB00116 0.403 0.049 DBMET00528 0.534 0.025 DBMET00506 | DBMET00506 | |
| 0.275 | 0.014 | 0.275 | DNA polymerase I inhibitor | 0.187 0.032 DBMET02314 0.24 0.019 DB00116 0.12 0.068 DBMET02316 0.149 0.05 DBMET00528 | ||
| 0.269 | 0.024 | 0.307 | Growth factor agonist | 0.203 0.06 DBMET02314 0.307 0.014 DB00116 0.272 0.023 DBMET00528 | DB00116 | |
| 0.289 | 0.054 | 0.34 | Interleukin agonist | 0.277 0.06 DB00116 0.34 0.032 DBMET00528 0.302 0.047 DBMET00506 | DBMET00528 | |
| 0.247 | 0.017 | 0.247 | Alkylator | 0.117 0.071 DBMET02314 0.154 0.044 DB00116 0.121 0.067 DBMET00528 0.246 0.017 DBMET00506 | ||
| 0.222 | 0.007 | 0.222 | DNA repair enzyme inhibitor | 0.15 0.032 DBMET00528 | ||
| 0.222 | 0.051 | 0.589 | Growth hormone agonist | 0.19 0.063 DBMET02314 0.19 0.063 DB00116 0.283 0.036 DBMET02316 0.176 0.07 DBMET00528 0.589 0.004 DBMET00506 | DBMET00506 | |
| 0.201 | 0.031 | 0.201 | Catenin beta inhibitor | 0.183 0.048 DBMET02314 0.168 0.069 DB00116 0.177 0.056 DBMET00528 | ||
| 0.258 | 0.089 | 0.332 | Insulysin inhibitor | 0.224 0.123 DBMET02314 0.252 0.094 DB00116 0.226 0.121 DBMET00528 0.332 0.041 DBMET00506 | DBMET00506 | |
| 0.271 | 0.108 | 0.321 | Apoptosis antagonist | 0.23 0.147 DBMET02314 0.212 0.164 DB00116 0.321 0.072 DBMET00506 | DBMET00506 | |
| 0.282 | 0.127 | 0.326 | Immunosuppressant | 0.231 0.165 DB00116 0.256 0.143 DBMET00528 0.326 0.1 DBMET00506 | DBMET00506 | |
| 0.188 | 0.058 | 0.466 | Thrombolytic | 0.157 0.077 DBMET02314 0.174 0.065 DB00116 0.194 0.055 DBMET00528 0.466 0.006 DBMET00506 | DBMET00506 | |
| 0.177 | 0.062 | 0.326 | Anticoagulant | 0.152 0.078 DBMET02314 0.185 0.059 DB00116 0.246 0.04 DBMET00528 0.326 0.024 DBMET00506 | DBMET00506 | |
| 0.261 | 0.147 | 0.594 | Histamine release inhibitor | 0.594 0.011 DBMET00506 | DBMET00506 | |
| 0.205 | 0.092 | 0.441 | Angiogenesis stimulant | 0.152 0.121 DBMET02314 0.178 0.106 DB00116 0.141 0.129 DBMET02316 0.166 0.113 DBMET00528 0.441 0.016 DBMET00506 | DBMET00506 | |
| 0.14 | 0.038 | 0.238 | Nav1.4 sodium channel blocker | 0.123 0.05 DBMET02314 0.132 0.043 DB00116 0.109 0.063 DBMET02316 0.126 0.047 DBMET00528 0.238 0.011 DBMET00506 | DBMET00506 | |
| 0.085 | 0.002 | 0.159 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.085 0.002 DBMET02314 0.159 0.001 DB00116 0.019 0.002 DBMET02316 0.094 0.002 DBMET00528 0.007 0.005 DBMET00506 | DB00116 | |
| 0.24 | 0.157 | 0.24 | Toll-Like receptor agonist | |||
| 0.135 | 0.056 | 0.248 | Cell adhesion inhibitor | 0.142 0.051 DBMET02314 0.14 0.053 DB00116 0.097 0.096 DBMET02316 0.131 0.058 DBMET00528 0.248 0.015 DBMET00506 | DBMET00506 | |
| 0.103 | 0.029 | 0.514 | Glutamate dehydrogenase inhibitor | 0.075 0.05 DB00116 0.1 0.031 DBMET00528 0.514 0.003 DBMET00506 | DBMET00506 | |
| 0.141 | 0.069 | 0.45 | Histone deacetylase SIRT1 inhibitor | 0.112 0.101 DB00116 0.109 0.106 DBMET00528 0.45 0.004 DBMET00506 | DBMET00506 | |
| 0.118 | 0.051 | 0.118 | Check point kinase 2 inhibitor | 0.099 0.066 DB00116 | ||
| 0.072 | 0.012 | 0.076 | Adenosine deaminase inhibitor | 0.076 0.01 DBMET00506 | DBMET00506 | |
| 0.178 | 0.119 | 0.408 | Platelet antagonist | 0.16 0.134 DBMET02314 0.164 0.131 DBMET00528 0.408 0.025 DBMET00506 | DBMET00506 | |
| 0.213 | 0.155 | 0.227 | Angiogenesis inhibitor | 0.227 0.141 DB00116 | DB00116 | |
| 0.087 | 0.033 | 0.663 | Phenylalanine 4-hydroxylase inhibitor | 0.167 0.01 DB00116 0.131 0.015 DBMET00528 0.663 0.002 DBMET00506 | DBMET00506 | |
| 0.069 | 0.018 | 0.076 | Complement C3a chemotactic receptor antagonist | 0.076 0.015 DBMET02314 0.073 0.016 DB00116 0.064 0.02 DBMET02316 0.065 0.019 DBMET00528 0.075 0.016 DBMET00506 | DBMET02314 | |
| 0.223 | 0.175 | 0.223 | Toll-Like receptor 7 agonist | |||
| 0.177 | 0.138 | 0.21 | RNA-directed DNA polymerase inhibitor | 0.21 0.085 DBMET00506 | DBMET00506 | |
| 0.106 | 0.069 | 0.222 | Chelator | 0.152 0.035 DBMET02316 0.222 0.021 DBMET00506 | DBMET00506 | |
| 0.038 | 0.002 | 0.038 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.024 0.004 DBMET02314 0.028 0.003 DB00116 0.018 0.009 DBMET00528 | ||
| 0.044 | 0.009 | 0.051 | Tryptophan 5 hydroxylase inhibitor | 0.036 0.024 DB00116 0.045 0.009 DBMET00528 0.051 0.005 DBMET00506 | DBMET00506 | |
| 0.057 | 0.022 | 0.468 | Farnesyltransferase inhibitor | 0.468 0.003 DBMET00506 | DBMET00506 | |
| 0.064 | 0.034 | 0.286 | Argininosuccinate synthase inhibitor | 0.051 0.046 DBMET00528 0.286 0.004 DBMET00506 | DBMET00506 | |
| 0.081 | 0.051 | 0.134 | Cell adhesion molecule inhibitor | 0.091 0.041 DBMET02314 0.089 0.043 DB00116 0.08 0.053 DBMET00528 0.134 0.019 DBMET00506 | DBMET00506 | |
| 0.066 | 0.036 | 0.08 | Caspase 9 inhibitor | 0.061 0.046 DBMET02314 0.08 0.023 DB00116 0.075 0.027 DBMET00528 0.065 0.038 DBMET00506 | DB00116 | |
| 0.093 | 0.066 | 0.11 | Interleukin 1 beta converting enzyme inhibitor | 0.11 0.045 DBMET02314 0.085 0.082 DBMET00528 | DBMET02314 | |
| 0.172 | 0.146 | 0.249 | Nitric-oxide synthase stimulant | 0.244 0.036 DB00116 0.249 0.033 DBMET00528 0.176 0.139 DBMET00506 | DBMET00528 | |
| 0.06 | 0.036 | 0.066 | Ribonucleotide reductase inhibitor | 0.066 0.033 DBMET00506 | DBMET00506 | |
| 0.097 | 0.075 | 0.114 | Factor V inhibitor | 0.099 0.072 DBMET02314 0.099 0.072 DB00116 0.095 0.083 DBMET02316 0.094 0.086 DBMET00528 0.114 0.045 DBMET00506 | DBMET00506 | |
| 0.07 | 0.048 | 0.07 | CDK1/cyclin B1 inhibitor | |||
| 0.142 | 0.124 | 0.396 | Interleukin antagonist | 0.396 0.031 DBMET00506 | DBMET00506 | |
| 0.08 | 0.064 | 0.08 | T cell inhibitor | |||
| 0.052 | 0.035 | 0.052 | Factor IXa inhibitor | |||
| 0.045 | 0.029 | 0.195 | Integrin antagonist | 0.092 0.018 DBMET02314 0.195 0.008 DB00116 0.044 0.029 DBMET02316 0.121 0.013 DBMET00528 0.152 0.01 DBMET00506 | DB00116 | |
| 0.039 | 0.024 | 0.067 | Integrin alpha1beta1 antagonist | 0.037 0.029 DBMET02314 0.039 0.025 DB00116 0.036 0.034 DBMET00528 0.067 0.004 DBMET00506 | DBMET00506 | |
| 0.02 | 0.007 | 0.026 | Tryptophan hydroxylase 1 inhibitor | 0.019 0.007 DB00116 0.018 0.01 DBMET00528 0.026 0.004 DBMET00506 | DBMET00506 | |
| 0.024 | 0.012 | 0.091 | Integrin alphaVbeta3 antagonist | 0.036 0.006 DBMET02314 0.091 0.004 DB00116 0.026 0.01 DBMET02316 0.047 0.005 DBMET00528 | DB00116 | |
| 0.051 | 0.04 | 0.066 | Ribonucleoside-diphosphate reductase inhibitor | 0.066 0.031 DBMET00506 | DBMET00506 | |
| 0.042 | 0.031 | 0.185 | Glutamate (mGluR group III) agonist | 0.185 0.004 DBMET00506 | DBMET00506 | |
| 0.059 | 0.049 | 0.152 | Glucagon-like peptide 1 agonist | 0.152 0.008 DBMET00506 | DBMET00506 | |
| 0.039 | 0.031 | 0.039 | Thymidine kinase inhibitor | |||
| 0.058 | 0.05 | 0.462 | NMDA receptor agonist | 0.083 0.027 DB00116 0.462 0.002 DBMET00506 | DBMET00506 | |
| 0.026 | 0.02 | 0.171 | Lysine carboxypeptidase inhibitor | 0.026 0.02 DB00116 0.171 0.002 DBMET00506 | DBMET00506 | |
| 0.038 | 0.033 | 0.092 | Integrin alpha5beta1 antagonist | 0.048 0.02 DBMET02314 0.092 0.005 DB00116 0.041 0.027 DBMET02316 0.079 0.007 DBMET00528 0.043 0.025 DBMET00506 | DB00116 | |
| 0.087 | 0.082 | 0.441 | GABA C receptor agonist | 0.441 0.004 DBMET00506 | DBMET00506 | |
| 0.037 | 0.032 | 0.267 | Erythropoietin receptor agonist | 0.267 0.005 DBMET00506 | DBMET00506 | |
| 0.118 | 0.115 | 0.321 | Insulin secretagoues | 0.212 0.03 DBMET02314 0.152 0.072 DB00116 0.119 0.113 DBMET02316 0.185 0.045 DBMET00528 0.321 0.01 DBMET00506 | DBMET00506 | |
| 0.028 | 0.026 | 0.041 | Caspase 2 inhibitor | 0.028 0.026 DBMET02314 0.041 0.015 DB00116 0.035 0.019 DBMET00528 | DB00116 | |
| 0.084 | 0.083 | 0.094 | Xanthine oxidase inhibitor | 0.094 0.066 DBMET00506 | DBMET00506 | |
| 0.019 | 0.018 | 0.114 | Geranylgeranyltransferase I inhibitor | 0.114 0.004 DBMET00506 | DBMET00506 | |
| 0.052 | 0.051 | 0.085 | Carbonic anhydrase stimulant | 0.085 0.024 DBMET00506 | DBMET00506 | |
| 0.052 | 0.052 | 0.467 | Carbamoyl phosphate synthetase inhibitor | 0.467 0.003 DBMET00506 | DBMET00506 | |
| 0.028 | 0.029 | 0.03 | Calcitonin receptor agonist | 0.03 0.027 DBMET00506 | DBMET00506 | |
| 0.01 | 0.011 | 0.011 | Purine nucleoside phosphorylase inhibitor | 0.011 0.01 DBMET00506 | DBMET00506 | |
| 0.016 | 0.019 | 0.069 | Integrin alphaVbeta1 antagonist | 0.031 0.006 DBMET02314 0.069 0.004 DB00116 0.022 0.01 DBMET02316 0.053 0.004 DBMET00528 | DB00116 | |
| 0.15 | 0.153 | 0.165 | MAP kinase kinase 5 inhibitor | 0.158 0.123 DBMET02314 0.163 0.105 DB00116 0.165 0.098 DBMET00528 | DBMET00528 | |
| 0.011 | 0.014 | 0.031 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.031 0.005 DBMET00506 | DBMET00506 | |
| 0.03 | 0.034 | 0.091 | Glutamate (mGluR4) agonist | 0.091 0.005 DBMET00506 | DBMET00506 | |
| 0.016 | 0.021 | 0.094 | Vitronectin receptor antagonist | 0.032 0.01 DBMET02314 0.094 0.005 DB00116 0.043 0.007 DBMET00528 | DB00116 | |
| 0.073 | 0.082 | 0.137 | Factor XII inhibitor | 0.076 0.074 DB00116 0.137 0.017 DBMET02316 0.082 0.062 DBMET00528 0.134 0.018 DBMET00506 | DBMET02316 | |
| 0.03 | 0.04 | 0.165 | Cholecystokinin B agonist | 0.04 0.023 DBMET00528 0.165 0.005 DBMET00506 | DBMET00506 | |
| 0.067 | 0.077 | 0.074 | Chymotrypsin inhibitor | 0.074 0.063 DBMET00506 | DBMET00506 | |
| 0.035 | 0.046 | 0.04 | Neurotensin receptor antagonist | 0.04 0.037 DBMET00506 | DBMET00506 | |
| 0.082 | 0.095 | 0.222 | Ferrochelatase inhibitor | 0.222 0.018 DBMET00506 | DBMET00506 | |
| 0.004 | 0.019 | 0.008 | DNA polymerase III subunit alpha inhibitor | 0.008 0.004 DBMET02314 0.008 0.004 DBMET00528 | DBMET00528 | |
| 0.012 | 0.028 | 0.05 | Integrin alpha4beta7 antagonist | 0.05 0.005 DBMET00506 | DBMET00506 | |
| 0.074 | 0.09 | 0.381 | Aminoacyl-tRNA synthetase inhibitor | 0.381 0.004 DBMET00506 | DBMET00506 | |
| 0.011 | 0.03 | 0.042 | Integrin beta3 antagonist | 0.042 0.007 DB00116 0.02 0.013 DBMET00528 | DB00116 | |
| 0.086 | 0.106 | 0.289 | Histone deacetylase class III inhibitor | 0.289 0.006 DBMET00506 | DBMET00506 | |
| 0.058 | 0.079 | 0.108 | Secretase beta inhibitor | 0.108 0.014 DBMET00506 | DBMET00506 | |
| 0.013 | 0.035 | 0.107 | Integrin alpha4 antagonist | 0.107 0.005 DBMET00506 | DBMET00506 | |
| 0.012 | 0.034 | 0.101 | VLA-4 antagonist | 0.034 0.016 DB00116 0.101 0.005 DBMET00506 | DBMET00506 | |
| 0.036 | 0.058 | 0.804 | Ornithine carbamoyltransferase inhibitor | 0.804 0.001 DBMET00506 | DBMET00506 | |
| 0.043 | 0.065 | 0.148 | CXC chemokine 4 receptor antagonist | 0.148 0.016 DB00116 | DB00116 | |
| 0.078 | 0.102 | 0.377 | Nitric-oxide synthase inhibitor | 0.125 0.035 DB00116 0.091 0.077 DBMET00528 0.377 0.004 DBMET00506 | DBMET00506 | |
| 0.019 | 0.043 | 0.084 | Prostacyclin antagonist | 0.084 0.005 DBMET00506 | DBMET00506 | |
| 0.018 | 0.043 | 0.025 | Bradykinin B2 receptor agonist | 0.025 0.024 DBMET00506 | DBMET00506 | |
| 0.041 | 0.067 | 0.051 | Carbonic anhydrase II stimulant | 0.051 0.037 DBMET00506 | DBMET00506 | |
| 0.012 | 0.041 | 0.029 | Integrin beta5 antagonist | 0.021 0.014 DBMET02314 0.029 0.009 DB00116 0.028 0.009 DBMET00528 | DB00116 | |
| 0.029 | 0.058 | 0.084 | GP IIb/IIIa receptor antagonist | 0.06 0.028 DB00116 0.05 0.032 DBMET00528 0.084 0.021 DBMET00506 | DBMET00506 | |
| 0.009 | 0.039 | 0.075 | Integrin beta7 antagonist | 0.075 0.005 DBMET00506 | DBMET00506 | |
| 0.033 | 0.064 | 0.043 | VCAM-1 antagonist | 0.043 0.017 DBMET00506 | DBMET00506 | |
| 0.033 | 0.064 | 0.043 | VCAM antagonist | 0.043 0.017 DBMET00506 | DBMET00506 | |
| 0.049 | 0.084 | 0.26 | Sirtuin 1 inhibitor | 0.26 0.003 DBMET00506 | DBMET00506 | |
| 0.024 | 0.059 | 0.048 | Carboxypeptidase B inhibitor | 0.048 0.008 DBMET00506 | DBMET00506 | |
| 0.027 | 0.063 | 0.091 | Glutamate (mGluR8) antagonist | 0.091 0.003 DBMET00506 | DBMET00506 | |
| 0.025 | 0.061 | 0.061 | Macrophage elastase inhibitor | 0.061 0.018 DBMET00506 | DBMET00506 | |
| 0.044 | 0.082 | 0.06 | Cathepsin E inhibitor | 0.056 0.047 DBMET02314 0.06 0.04 DBMET02316 | DBMET02316 | |
| 0.037 | 0.076 | 0.058 | HCV NS3/NS4A protease inhibitor | 0.058 0.023 DBMET00506 | DBMET00506 | |
| 0.026 | 0.066 | 0.074 | HCV polyprotein inhibitor | 0.074 0.004 DBMET02316 | DBMET02316 | |
| 0.004 | 0.045 | 0.067 | Glucagon agonist | 0.067 0.004 DBMET00506 | DBMET00506 | |
| 0.009 | 0.05 | 0.017 | Angiotensin-converting enzyme 2 inhibitor | 0.017 0.013 DBMET00506 | DBMET00506 | |
| 0.041 | 0.084 | 0.158 | Angiotensin-converting enzyme inhibitor | 0.158 0.005 DBMET00506 | DBMET00506 | |
| 0.021 | 0.066 | 0.035 | Carbonic anhydrase I stimulant | 0.035 0.029 DBMET00506 | DBMET00506 | |
| 0.115 | 0.162 | 0.547 | DNA methylase inhibitor | 0.547 0.005 DBMET00506 | DBMET00506 | |
| 0.08 | 0.13 | 0.156 | Caspase 3 inhibitor | 0.156 0.024 DBMET00506 | DBMET00506 | |
| 0.002 | 0.053 | 0.274 | Neurokinin 3 agonist | 0.274 0.002 DBMET00506 | DBMET00506 | |
| 0.035 | 0.086 | 0.049 | Bombesin 2 receptor antagonist | 0.049 0.034 DBMET00506 | DBMET00506 | |
| 0.02 | 0.08 | 0.037 | Growth factor receptor-bound protein 2 antagonist | 0.037 0.02 DBMET00506 | DBMET00506 | |
| 0.02 | 0.084 | 0.079 | Endothelin-converting enzyme inhibitor | 0.079 0.018 DBMET00506 | DBMET00506 | |
| 0.03 | 0.096 | 0.066 | Human rhinovirus A protease inhibitor | 0.066 0.031 DBMET00506 | DBMET00506 | |
| 0.08 | 0.148 | 0.203 | Toll-Like receptor 2 antagonist | 0.203 0.022 DBMET00506 | DBMET00506 | |
| 0.012 | 0.08 | 0.127 | Endothelial nitric-oxide synthase inhibitor | 0.045 0.011 DB00116 0.127 0.004 DBMET00506 | DBMET00506 | |
| 0.019 | 0.088 | 0.054 | Factor XIIIa inhibitor | 0.054 0.014 DBMET00506 | DBMET00506 | |
| 0.086 | 0.155 | 0.591 | Peroxidase inhibitor | 0.591 0.005 DBMET00506 | DBMET00506 | |
| 0.009 | 0.083 | 0.12 | Cholecystokinin A antagonist | 0.12 0.006 DBMET00528 0.086 0.011 DBMET00506 | DBMET00528 | |
| 0.005 | 0.079 | 0.072 | Neutral endopeptidase inhibitor | 0.072 0.005 DBMET00506 | DBMET00506 | |
| 0.007 | 0.081 | 0.087 | Cholecystokinin agonist | 0.087 0.005 DBMET00506 | DBMET00506 | |
| 0.029 | 0.104 | 0.166 | Aminopeptidase microsomal inhibitor | 0.166 0.005 DBMET00506 | DBMET00506 | |
| 0.005 | 0.083 | 0.036 | AMPA 1 receptor antagonist | 0.036 0.017 DBMET00506 | DBMET00506 | |
| 0.014 | 0.093 | 0.099 | Fumarate hydratase inhibitor | 0.099 0.005 DBMET00506 | DBMET00506 | |
| 0.02 | 0.1 | 0.143 | Aminopeptidase N inhibitor | 0.143 0.006 DBMET00506 | DBMET00506 | |
| 0.01 | 0.091 | 0.088 | Geranylgeranyltransferase inhibitor | 0.088 0.003 DBMET00506 | DBMET00506 | |
| 0.007 | 0.089 | 0.055 | Cholecystokinin A agonist | 0.015 0.012 DBMET00528 0.055 0.005 DBMET00506 | DBMET00506 | |
| 0.054 | 0.14 | 0.125 | Protease inhibitor | 0.125 0.044 DBMET00506 | DBMET00506 | |
| 0.028 | 0.114 | 0.102 | Selectin antagonist | 0.102 0.027 DBMET00506 | DBMET00506 | |
| 0.018 | 0.104 | 0.027 | DNA polymerase III inhibitor | 0.027 0.022 DBMET00528 | DBMET00528 | |
| 0.01 | 0.098 | 0.093 | Cholecystokinin antagonist | 0.093 0.009 DBMET00528 0.075 0.013 DBMET00506 | DBMET00528 | |
| 0.139 | 0.228 | 0.302 | Peptidyltransferase inhibitor | 0.167 0.154 DBMET00528 0.302 0.024 DBMET00506 | DBMET00506 | |
| 0.03 | 0.119 | 0.246 | Phosphofructokinase-1 inhibitor | 0.246 0.008 DBMET00506 | DBMET00506 | |
| 0.006 | 0.096 | 0.048 | Cholecystokinin B antagonist | 0.048 0.011 DBMET00506 | DBMET00506 | |
| 0.173 | 0.264 | 0.395 | Antibacterial | 0.214 0.213 DBMET02314 0.395 0.079 DBMET00506 | DBMET00506 | |
| 0.009 | 0.102 | 0.062 | AMPA 2 receptor antagonist | 0.062 0.009 DBMET00506 | DBMET00506 | |
| 0.026 | 0.119 | 0.055 | Bombesin antagonist | 0.055 0.023 DBMET00506 | DBMET00506 | |
| 0.005 | 0.098 | 0.074 | Human T-cell leukemia virus type I protease inhibitor | 0.074 0.003 DBMET00506 | DBMET00506 | |
| 0.029 | 0.124 | 0.065 | Cathepsin D inhibitor | 0.065 0.031 DBMET00506 | DBMET00506 | |
| 0.032 | 0.129 | 0.249 | Bombesin 1 receptor agonist | 0.249 0.004 DBMET00506 | DBMET00506 | |
| 0.006 | 0.103 | 0.06 | Growth hormone releasing factor antagonist | 0.06 0.005 DBMET00506 | DBMET00506 | |
| 0.007 | 0.106 | 0.024 | Aminopeptidase P inhibitor | 0.024 0.016 DBMET00506 | DBMET00506 | |
| 0.016 | 0.118 | 0.104 | NMDA 2A receptor antagonist | 0.104 0.012 DBMET00506 | DBMET00506 | |
| 0.022 | 0.126 | 0.436 | Neurokinin 2 agonist | 0.436 0.002 DBMET00506 | DBMET00506 | |
| 0.038 | 0.143 | 0.076 | Adenine nucleotide translocase inhibitor | 0.076 0.011 DBMET00506 | DBMET00506 | |
| 0.035 | 0.143 | 0.082 | Protein kinase C alpha inhibitor | 0.082 0.032 DBMET00528 | DBMET00528 | |
| 0.018 | 0.128 | 0.162 | Glutamate (mGluR3) agonist | 0.162 0.001 DBMET00506 | DBMET00506 | |
| 0.035 | 0.148 | 0.066 | DNA helicase inhibitor | 0.066 0.02 DBMET00506 | DBMET00506 | |
| 0.058 | 0.173 | 0.297 | Adenylate cyclase inhibitor | 0.297 0.014 DBMET00506 | DBMET00506 | |
| 0.018 | 0.134 | 0.139 | Membrane dipeptidase inhibitor | 0.139 0.002 DBMET00506 | DBMET00506 | |
| 0.005 | 0.125 | 0.198 | Arginase inhibitor | 0.198 0.002 DBMET00506 | DBMET00506 | |
| 0.014 | 0.14 | 0.259 | Toll-Like receptor 2 agonist | 0.259 0.004 DBMET00506 | DBMET00506 | |
| 0.003 | 0.134 | 0.11 | Aminopeptidase A inhibitor | 0.11 0.002 DBMET00506 | DBMET00506 | |
| 0.028 | 0.164 | 0.083 | Parathyroid hormone antagonist | 0.083 0.004 DBMET00506 | DBMET00506 | |
| 0.075 | 0.211 | 0.273 | Diuretic | 0.273 0.027 DBMET00506 | DBMET00506 | |
| 0.006 | 0.145 | 0.038 | Neurokinin 1 agonist | 0.038 0.008 DBMET00506 | DBMET00506 | |
| 0.038 | 0.179 | 0.073 | Somatostatin 1 agonist | 0.073 0.061 DBMET00506 | DBMET00506 | |
| 0.026 | 0.168 | 0.325 | Catalase inhibitor | 0.325 0.005 DBMET00506 | DBMET00506 | |
| 0.02 | 0.165 | 0.147 | Glutamate (mGluR8) agonist | 0.147 0.002 DBMET00506 | DBMET00506 | |
| 0.067 | 0.214 | 0.114 | Antibacterial (Helicobacter pylori) | 0.114 0.091 DBMET00506 | DBMET00506 | |
| 0.016 | 0.167 | 0.051 | Collagenase inhibitor | 0.051 0.03 DBMET00506 | DBMET00506 | |
| 0.012 | 0.166 | 0.052 | Bombesin 1 receptor antagonist | 0.052 0.012 DBMET00506 | DBMET00506 | |
| 0.038 | 0.198 | 0.689 | Aminopeptidase B inhibitor | 0.689 0.002 DBMET00506 | DBMET00506 | |
| 0.075 | 0.239 | 0.252 | Thiol protease inhibitor | 0.252 0.026 DBMET00506 | DBMET00506 | |
| 0.015 | 0.181 | 0.075 | Mannosidase inhibitor | 0.075 0.01 DBMET00506 | DBMET00506 | |
| 0.029 | 0.197 | 0.213 | Aminopeptidase I inhibitor | 0.213 0.006 DBMET00506 | DBMET00506 | |
| 0.005 | 0.174 | 0.163 | Leukotriene A4 hydrolase inhibitor | 0.163 0.005 DBMET00506 | DBMET00506 | |
| 0.013 | 0.186 | 0.241 | Glycine transporter 2 inhibitor | 0.241 0.004 DBMET00506 | DBMET00506 | |
| 0.005 | 0.178 | 0.036 | Kainate receptor 3 antagonist | 0.036 0.005 DBMET00506 | DBMET00506 | |
| 0.076 | 0.249 | 0.375 | Insulin sensitizer | 0.375 0.008 DBMET00506 | DBMET00506 | |
| 0.007 | 0.185 | 0.028 | AMPA 3 receptor antagonist | 0.028 0.022 DBMET00506 | DBMET00506 | |
| 0.102 | 0.28 | 0.209 | Neurotensin receptor agonist | 0.209 0.03 DBMET00506 | DBMET00506 | |
| 0.013 | 0.193 | 0.125 | NMDA 2C receptor antagonist | 0.125 0.01 DBMET00506 | DBMET00506 | |
| 0.025 | 0.206 | 0.589 | Glutamate decarboxylase inhibitor | 0.589 0.002 DBMET00506 | DBMET00506 | |
| 0.023 | 0.204 | 0.409 | Histidine decarboxylase inhibitor | 0.409 0.004 DBMET00506 | DBMET00506 | |
| 0.022 | 0.208 | 0.127 | Glutamate (mGluR4) antagonist | 0.127 0.004 DBMET00506 | DBMET00506 | |
| 0.005 | 0.193 | 0.039 | Kainate receptor 5 antagonist | 0.039 0.007 DBMET00506 | DBMET00506 | |
| 0.044 | 0.232 | 0.09 | GABA B receptor agonist | 0.09 0.026 DBMET00506 | DBMET00506 | |
| 0.002 | 0.195 | 0.1 | Glutamate (mGluR6) agonist | 0.1 0.002 DBMET00506 | DBMET00506 | |
| 0.057 | 0.25 | 0.34 | Adenylate kinase inhibitor | 0.34 0.005 DBMET00506 | DBMET00506 | |
| 0.046 | 0.239 | 0.104 | Thioredoxin inhibitor | 0.104 0.044 DBMET02316 | DBMET02316 | |
| 0.052 | 0.248 | 0.474 | Psychostimulant | 0.474 0.013 DBMET00506 | DBMET00506 | |
| 0.02 | 0.223 | 0.072 | Nitric oxide donor | 0.072 0.031 DBMET00506 | DBMET00506 | |
| 0.007 | 0.214 | 0.033 | Opioid delta receptor agonist | 0.033 0.028 DBMET00506 | DBMET00506 | |
| 0.006 | 0.215 | 0.04 | Glucagon receptor antagonist | 0.04 0.014 DBMET00506 | DBMET00506 | |
| 0.033 | 0.246 | 0.169 | Opioid antagonist | 0.09 0.057 DBMET00528 0.169 0.021 DBMET00506 | DBMET00506 | |
| 0.023 | 0.238 | 0.144 | Botulinum neurotoxin type A inhibitor | 0.144 0.005 DBMET00506 | DBMET00506 | |
| 0.006 | 0.222 | 0.035 | Kainate receptor 4 antagonist | 0.035 0.011 DBMET00506 | DBMET00506 | |
| 0.087 | 0.304 | 0.681 | Phospholipase C inhibitor | 0.681 0.003 DBMET00506 | DBMET00506 | |
| 0.024 | 0.24 | 0.066 | Phospholipase D inhibitor | 0.066 0.062 DBMET02316 | DBMET02316 | |
| 0.01 | 0.23 | 0.245 | Glutamate (mGluR1) agonist | 0.245 0.002 DBMET00506 | DBMET00506 | |
| 0.013 | 0.241 | 0.159 | Glutamate (mGluR) agonist | 0.159 0.013 DBMET00506 | DBMET00506 | |
| 0.035 | 0.263 | 0.092 | Protein kinase C mu inhibitor | 0.092 0.065 DBMET00528 | DBMET00528 | |
| 0.015 | 0.245 | 0.088 | Biliverdin reductase inhibitor | 0.088 0.023 DBMET00506 | DBMET00506 | |
| 0.068 | 0.298 | 0.362 | Hepatoprotectant | 0.132 0.131 DBMET00528 0.362 0.017 DBMET00506 | DBMET00506 | |
| 0.097 | 0.331 | 0.244 | Gastrin inhibitor | 0.244 0.087 DBMET00506 | DBMET00506 | |
| 0.012 | 0.246 | 0.173 | Opioid delta receptor antagonist | 0.088 0.033 DBMET00528 0.173 0.015 DBMET00506 | DBMET00506 | |
| 0.043 | 0.279 | 0.182 | Bone formation stimulant | 0.182 0.041 DBMET00506 | DBMET00506 | |
| 0.113 | 0.35 | 0.303 | Sodium/bile acid cotransporter inhibitor | 0.303 0.076 DBMET00506 | DBMET00506 | |
| 0.005 | 0.244 | 0.202 | Glutamate (mGluR1a) agonist | 0.202 0.002 DBMET00506 | DBMET00506 | |
| 0.018 | 0.257 | 0.111 | Histone deacetylase SIRT2 inhibitor | 0.111 0.021 DBMET00506 | DBMET00506 | |
| 0.017 | 0.257 | 0.089 | Aconitate hydratase inhibitor | 0.089 0.011 DBMET00506 | DBMET00506 | |
| 0.049 | 0.296 | 0.145 | Glutamate (mGluR7) agonist | 0.145 0.014 DBMET00506 | DBMET00506 | |
| 0.009 | 0.256 | 0.049 | Glutamate (mGluR group II) agonist | 0.049 0.016 DBMET00506 | DBMET00506 | |
| 0.034 | 0.282 | 0.22 | Glutamate (mGluR6) antagonist | 0.22 0.003 DBMET00506 | DBMET00506 | |
| 0.014 | 0.263 | 0.071 | Lysophosphatidic acid 3 receptor antagonist | 0.071 0.014 DBMET00506 | DBMET00506 | |
| 0.018 | 0.274 | 0.197 | Porphobilinogen synthase inhibitor | 0.197 0.013 DBMET00506 | DBMET00506 | |
| 0.03 | 0.288 | 0.09 | Gastric antisecretory | 0.09 0.078 DBMET00506 | DBMET00506 | |
| 0.019 | 0.279 | 0.051 | Cathepsin F inhibitor | 0.051 0.011 DBMET00506 | DBMET00506 | |
| 0.024 | 0.286 | 0.106 | GABA aminotransferase inhibitor | 0.106 0.023 DBMET00506 | DBMET00506 | |
| 0.007 | 0.274 | 0.08 | NMDA 2 receptor antagonist | 0.08 0.043 DBMET00506 | DBMET00506 | |
| 0.008 | 0.274 | 0.053 | Opioid mu receptor agonist | 0.053 0.027 DBMET00506 | DBMET00506 | |
| 0.007 | 0.276 | 0.054 | LFA antagonist | 0.054 0.005 DBMET00506 | DBMET00506 | |
| 0.038 | 0.314 | 0.101 | NADH dehydrogenase inhibitor | 0.101 0.042 DBMET00506 | DBMET00506 | |
| 0.036 | 0.312 | 0.355 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.355 0.004 DBMET00506 | DBMET00506 | |
| 0.022 | 0.298 | 0.068 | Cathepsin G inhibitor | 0.068 0.056 DBMET00506 | DBMET00506 | |
| 0.013 | 0.293 | 0.187 | Glutamate receptor agonist | 0.187 0.012 DBMET00506 | DBMET00506 | |
| 0.009 | 0.294 | 0.056 | Oxytocin agonist | 0.056 0.019 DBMET00506 | DBMET00506 | |
| 0.025 | 0.311 | 0.107 | Protein kinase C delta inhibitor | 0.107 0.046 DBMET00528 | DBMET00528 | |
| 0.006 | 0.294 | 0.058 | AMPA receptor agonist | 0.049 0.009 DBMET02316 0.058 0.006 DBMET00506 | DBMET00506 | |
| 0.011 | 0.303 | 0.141 | NMDA receptor glycine site agonist | 0.141 0.005 DBMET00506 | DBMET00506 | |
| 0.029 | 0.322 | 0.077 | Histone deacetylase SIRT3 inhibitor | 0.077 0.02 DBMET00506 | DBMET00506 | |
| 0.019 | 0.312 | 0.135 | Metalloproteinase-2 inhibitor | 0.135 0.023 DBMET00506 | DBMET00506 | |
| 0.087 | 0.38 | 0.383 | Antithrombotic | 0.383 0.054 DBMET00506 | DBMET00506 | |
| 0.002 | 0.297 | 0.012 | Integrin beta2 antagonist | 0.012 0.009 DBMET00506 | DBMET00506 | |
| 0.053 | 0.35 | 0.538 | DNA methyltransferase I inhibitor | 0.538 0.004 DBMET00506 | DBMET00506 | |
| 0.011 | 0.313 | 0.144 | Opioid mu receptor antagonist | 0.144 0.019 DBMET00506 | DBMET00506 | |
| 0.014 | 0.32 | 0.104 | NMDA receptor antagonist | 0.104 0.044 DBMET00506 | DBMET00506 | |
| 0.011 | 0.317 | 0.133 | AMPA 4 receptor antagonist | 0.133 0.004 DBMET00506 | DBMET00506 | |
| 0.032 | 0.344 | 0.068 | Lipocortins synthesis agonist | 0.057 0.043 DBMET00528 0.068 0.024 DBMET00506 | DBMET00506 | |
| 0.008 | 0.321 | 0.048 | NMDA receptor subunit 3B antagonist | 0.048 0.027 DBMET00506 | DBMET00506 | |
| 0.005 | 0.318 | 0.035 | Glutamate (mGluR2) agonist | 0.035 0.021 DBMET00506 | DBMET00506 | |
| 0.132 | 0.446 | 0.321 | 5 Hydroxytryptamine release inhibitor | 0.321 0.143 DBMET00506 | DBMET00506 | |
| 0.025 | 0.339 | 0.154 | Ornithine decarboxylase inhibitor | 0.154 0.01 DBMET00506 | DBMET00506 | |
| 0.014 | 0.333 | 0.165 | Sphingosine 1-phosphate receptor 4 agonist | 0.165 0.006 DBMET00506 | DBMET00506 | |
| 0.006 | 0.328 | 0.033 | Calcium-sensing receptor agonist | 0.033 0.011 DBMET00506 | DBMET00506 | |
| 0.017 | 0.345 | 0.364 | Inducible nitric-oxide synthase inhibitor | 0.364 0.004 DBMET00506 | DBMET00506 | |
| 0.008 | 0.338 | 0.087 | Neutrophil collagenase inhibitor | 0.087 0.028 DBMET00506 | DBMET00506 | |
| 0.004 | 0.336 | 0.039 | Carbonic anhydrase IV inhibitor | 0.039 0.034 DBMET00506 | DBMET00506 | |
| 0.031 | 0.369 | 0.143 | Lipid peroxidase inhibitor | 0.143 0.073 DBMET00506 | DBMET00506 | |
| 0.002 | 0.341 | 0.037 | Ileal bile acid transport inhibitor | 0.037 0.004 DBMET00506 | DBMET00506 | |
| 0.033 | 0.373 | 0.087 | Electrolyte absorption antagonist | 0.087 0.079 DBMET00506 | DBMET00506 | |
| 0.016 | 0.362 | 0.108 | Analgesic, opioid | 0.108 0.027 DBMET00506 | DBMET00506 | |
| 0.101 | 0.447 | 0.514 | Tyrosine 3 hydroxylase inhibitor | 0.514 0.004 DBMET00506 | DBMET00506 | |
| 0.007 | 0.357 | 0.044 | Nicotinic receptor beta4 subunit antagonist | 0.044 0.019 DBMET00506 | DBMET00506 | |
| 0.038 | 0.388 | 0.258 | Cell wall synthesis inhibitor | 0.258 0.014 DBMET00506 | DBMET00506 | |
| 0.007 | 0.358 | 0.021 | Methylmalonyl-CoA mutase inhibitor | 0.021 0.007 DBMET00506 | DBMET00506 | |
| 0.028 | 0.381 | 0.093 | Opioid kappa receptor antagonist | 0.093 0.043 DBMET00528 | DBMET00528 | |
| 0.03 | 0.389 | 0.136 | Proteasome inhibitor | 0.136 0.055 DBMET00506 | DBMET00506 | |
| 0.016 | 0.377 | 0.112 | Glutamate (mGluR group III) antagonist | 0.112 0.005 DBMET00506 | DBMET00506 | |
| 0.014 | 0.383 | 0.123 | Kainate receptor agonist | 0.123 0.002 DBMET00506 | DBMET00506 | |
| 0.004 | 0.382 | 0.041 | NMDA receptor subunit 3A antagonist | 0.041 0.024 DBMET00506 | DBMET00506 | |
| 0.048 | 0.428 | 0.261 | Antioxidant | 0.261 0.078 DBMET00506 | DBMET00506 | |
| 0.002 | 0.382 | 0.046 | Kainate receptor 1 antagonist | 0.046 0.006 DBMET00506 | DBMET00506 | |
| 0.013 | 0.395 | 0.116 | Metalloproteinase-9 inhibitor | 0.116 0.026 DBMET00506 | DBMET00506 | |
| 0.041 | 0.424 | 0.253 | Free radical scavenger | 0.253 0.067 DBMET00506 | DBMET00506 | |
| 0.026 | 0.41 | 0.103 | GABA C receptor rho-1 antagonist | 0.103 0.058 DBMET00506 | DBMET00506 | |
| 0.006 | 0.394 | 0.083 | Metalloproteinase-3 inhibitor | 0.083 0.015 DBMET00506 | DBMET00506 | |
| 0.006 | 0.406 | 0.129 | Glutamate (mGluR3) antagonist | 0.129 0.004 DBMET00506 | DBMET00506 | |
| 0.023 | 0.425 | 0.295 | Glutathione S-transferase inhibitor | 0.295 0.003 DBMET00506 | DBMET00506 | |
| 0.032 | 0.436 | 0.104 | Lanosterol 14 alpha demethylase inhibitor | 0.104 0.05 DBMET00506 | DBMET00506 | |
| 0.003 | 0.408 | 0.128 | Kainate receptor antagonist | 0.128 0.005 DBMET00506 | DBMET00506 | |
| 0.014 | 0.421 | 0.18 | M17 leucyl aminopeptidase inhibitor | 0.18 0.04 DBMET00506 | DBMET00506 | |
| 0.038 | 0.444 | 0.238 | Calpain inhibitor | 0.238 0.076 DBMET00506 | DBMET00506 | |
| 0.061 | 0.468 | 0.291 | Hypoglycemic | 0.291 0.056 DBMET00506 | DBMET00506 | |
| 0.007 | 0.418 | 0.03 | ICAM 1 antagonist | 0.03 0.007 DBMET00506 | DBMET00506 | |
| 0.013 | 0.425 | 0.048 | Dipeptidyl peptidase inhibitor | 0.048 0.046 DBMET00506 | DBMET00506 | |
| 0.037 | 0.45 | 0.207 | Antiamyloidogenic | 0.207 0.095 DBMET00506 | DBMET00506 | |
| 0.009 | 0.422 | 0.041 | p53 inhibitor | 0.041 0.02 DBMET00506 | DBMET00506 | |
| 0.057 | 0.471 | 0.794 | Superoxide dismutase inhibitor | 0.794 0.003 DBMET00506 | DBMET00506 | |
| 0.014 | 0.439 | 0.162 | Alcohol dehydrogenase inhibitor | 0.162 0.017 DBMET00506 | DBMET00506 | |
| 0.008 | 0.434 | 0.078 | Matrix metalloproteinase (membrane-type) inhibitor | 0.078 0.021 DBMET00506 | DBMET00506 | |
| 0.006 | 0.433 | 0.053 | Peptide deformylase inhibitor | 0.053 0.009 DBMET00506 | DBMET00506 | |
| 0.038 | 0.467 | 0.127 | Nitric oxide antagonist | 0.127 0.124 DBMET00506 | DBMET00506 | |
| 0.026 | 0.457 | 0.193 | Triose-phosphate isomerase inhibitor | 0.193 0.012 DBMET00506 | DBMET00506 | |
| 0.051 | 0.483 | 0.393 | Transcription factor NF kappa B inhibitor | 0.393 0.065 DBMET00506 | DBMET00506 | |
| 0.085 | 0.518 | 0.324 | Cyclophilin D inhibitor | 0.324 0.143 DBMET00506 | DBMET00506 | |
| 0.025 | 0.46 | 0.216 | Cathepsin H inhibitor | 0.216 0.019 DBMET00506 | DBMET00506 | |
| 0.003 | 0.439 | 0.116 | Kainate receptor 2 antagonist | 0.116 0.004 DBMET00506 | DBMET00506 | |
| 0.038 | 0.48 | 0.269 | Vasodilator | 0.269 0.06 DBMET00506 | DBMET00506 | |
| 0.013 | 0.457 | 0.062 | Glucose-6-phosphate isomerase inhibitor | 0.062 0.017 DBMET00506 | DBMET00506 | |
| 0.016 | 0.465 | 0.295 | Mucolytic | 0.295 0.004 DBMET00506 | DBMET00506 | |
| 0.023 | 0.474 | 0.356 | Alpha-N-acetylglucosaminidase inhibitor | 0.356 0.011 DBMET00506 | DBMET00506 | |
| 0.017 | 0.481 | 0.173 | Cystathionine beta-synthase inhibitor | 0.173 0.032 DBMET00506 | DBMET00506 | |
| 0.019 | 0.487 | 0.143 | Neurotrophic factor | 0.143 0.065 DBMET00506 | DBMET00506 | |
| 0.012 | 0.481 | 0.04 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.04 0.031 DBMET00506 | DBMET00506 | |
| 0.007 | 0.483 | 0.098 | Matrix metalloproteinase inhibitor | 0.098 0.027 DBMET00506 | DBMET00506 | |
| 0.003 | 0.483 | 0.096 | Methionyl aminopeptidase 1 inhibitor | 0.096 0.004 DBMET00506 | DBMET00506 | |
| 0.036 | 0.518 | 0.13 | Antipruritic | 0.13 0.123 DBMET00506 | DBMET00506 | |
| 0.029 | 0.513 | 0.2 | Photosensitizer | 0.2 0.013 DBMET00506 | DBMET00506 | |
| 0.008 | 0.493 | 0.088 | Alpha-mannosidase inhibitor | 0.088 0.009 DBMET00506 | DBMET00506 | |
| 0.001 | 0.488 | 0.027 | Carbonic anhydrase VIII inhibitor | 0.027 0.005 DBMET00506 | DBMET00506 | |
| 0.001 | 0.488 | 0.027 | Carbonic anhydrase X inhibitor | 0.027 0.005 DBMET00506 | DBMET00506 | |
| 0.025 | 0.517 | 0.176 | DOPA decarboxylase inhibitor | 0.176 0.011 DBMET00506 | DBMET00506 | |
| 0.004 | 0.499 | 0.043 | Leukocyte elastase inhibitor | 0.043 0.029 DBMET00506 | DBMET00506 | |
| 0.01 | 0.505 | 0.321 | Expectorant | 0.321 0.007 DBMET00506 | DBMET00506 | |
| 0.012 | 0.508 | 0.113 | Protease 3C (Human rhinovirus) inhibitor | 0.113 0.011 DBMET00506 | DBMET00506 | |
| 0.005 | 0.511 | 0.115 | Tyk2 inhibitor | 0.115 0.022 DBMET02316 | DBMET02316 | |
| 0.022 | 0.538 | 0.252 | Interleukin 8 antagonist | 0.252 0.005 DBMET00506 | DBMET00506 | |
| 0.005 | 0.527 | 0.085 | Prostaglandin EP2 antagonist | 0.085 0.024 DBMET00506 | DBMET00506 | |
| 0.041 | 0.564 | 0.143 | Vanilloid 1 agonist | 0.143 0.045 DBMET00506 | DBMET00506 | |
| 0.031 | 0.555 | 0.21 | Interleukin 6 antagonist | 0.21 0.035 DBMET00506 | DBMET00506 | |
| 0.017 | 0.543 | 0.101 | Keratolytic | 0.101 0.03 DBMET00506 | DBMET00506 | |
| 0.014 | 0.544 | 0.144 | GABA C receptor antagonist | 0.144 0.033 DBMET00506 | DBMET00506 | |
| 0.014 | 0.544 | 0.208 | Histamine N-methyltransferase inhibitor | 0.208 0.005 DBMET00506 | DBMET00506 | |
| 0.032 | 0.568 | 0.168 | Cardiotonic | 0.168 0.154 DBMET00506 | DBMET00506 | |
| 0.004 | 0.541 | 0.054 | Cathepsin L inhibitor | 0.054 0.045 DBMET00506 | DBMET00506 | |
| 0.031 | 0.568 | 0.235 | Adenylate cyclase stimulant | 0.235 0.005 DBMET00506 | DBMET00506 | |
| 0.015 | 0.557 | 0.251 | Phospholipase A2 inhibitor | 0.251 0.023 DBMET00506 | DBMET00506 | |
| 0.017 | 0.559 | 0.053 | Vanilloid 2 antagonist | 0.053 0.035 DBMET00506 | DBMET00506 | |
| 0.005 | 0.548 | 0.171 | Acyl-CoA dehydrogenase inhibitor | 0.171 0.007 DBMET00506 | DBMET00506 | |
| 0.042 | 0.585 | 0.255 | Cholesterol antagonist | 0.255 0.121 DBMET00506 | DBMET00506 | |
| 0.002 | 0.547 | 0.022 | Purinergic P2Y1 agonist | 0.022 0.006 DBMET00506 | DBMET00506 | |
| 0.028 | 0.574 | 0.078 | D-Ala-D-Ala ligase inhibitor | 0.078 0.075 DBMET00506 | DBMET00506 | |
| 0.076 | 0.625 | 0.147 | Heat shock protein 70 antagonist | 0.147 0.052 DBMET00506 | DBMET00506 | |
| 0.006 | 0.557 | 0.062 | Collagenase 3 inhibitor | 0.062 0.039 DBMET00506 | DBMET00506 | |
| 0.003 | 0.559 | 0.053 | Geranyltranstransferase inhibitor | 0.053 0.02 DBMET00506 | DBMET00506 | |
| 0.025 | 0.587 | 0.341 | Cyclooxygenase 3 inhibitor | 0.341 0.005 DBMET00506 | DBMET00506 | |
| 0.015 | 0.578 | 0.194 | Prolactin inhibitor | 0.194 0.01 DBMET00506 | DBMET00506 | |
| 0.004 | 0.573 | 0.043 | Glutamate (mGluR group I) agonist | 0.043 0.039 DBMET00506 | DBMET00506 | |
| 0.004 | 0.576 | 0.054 | Kinesin antagonist | 0.054 0.015 DBMET00506 | DBMET00506 | |
| 0.004 | 0.576 | 0.054 | Kinesin-like protein 1 inhibitor | 0.054 0.015 DBMET00506 | DBMET00506 | |
| 0.005 | 0.578 | 0.04 | Dipeptidyl peptidase II inhibitor | 0.04 0.015 DBMET00506 | DBMET00506 | |
| 0.023 | 0.601 | 0.269 | Succinate dehydrogenase inhibitor | 0.269 0.017 DBMET00506 | DBMET00506 | |
| 0.004 | 0.586 | 0.102 | Alcohol oxidase inhibitor | 0.102 0.018 DBMET00506 | DBMET00506 | |
| 0.009 | 0.602 | 0.102 | Urease inhibitor | 0.102 0.065 DBMET00506 | DBMET00506 | |
| 0.024 | 0.618 | 0.265 | Calpain 2 inhibitor | 0.265 0.139 DBMET00506 | DBMET00506 | |
| 0.026 | 0.621 | 0.299 | Transcription factor STAT3 inhibitor | 0.299 0.054 DBMET00506 | DBMET00506 | |
| 0.025 | 0.622 | 0.125 | Melanin inhibitor | 0.125 0.124 DBMET00506 | DBMET00506 | |
| 0.004 | 0.601 | 0.026 | Lysophosphatidic acid receptor 1 agonist | 0.026 0.015 DBMET00506 | DBMET00506 | |
| 0.032 | 0.631 | 0.259 | Neuropeptide Y2 antagonist | 0.259 0.048 DBMET00506 | DBMET00506 | |
| 0.003 | 0.603 | 0.059 | Matrix metalloproteinase 1 inhibitor | 0.059 0.032 DBMET00506 | DBMET00506 | |
| 0.009 | 0.613 | 0.094 | Glutamate (mGluR7) antagonist | 0.094 0.014 DBMET00506 | DBMET00506 | |
| 0.013 | 0.625 | 0.142 | Sphingosine 1-phosphate receptor 2 antagonist | 0.142 0.052 DBMET00506 | DBMET00506 | |
| 0.074 | 0.69 | 0.482 | 5 Hydroxytryptamine uptake stimulant | 0.482 0.005 DBMET00506 | DBMET00506 | |
| 0.002 | 0.623 | 0.041 | Isoleucine-tRNA ligase inhibitor | 0.041 0.003 DBMET00506 | DBMET00506 | |
| 0.01 | 0.632 | 0.18 | Pyruvate kinase inhibitor | 0.18 0.093 DBMET00506 | DBMET00506 | |
| 0.002 | 0.633 | 0.092 | Sirtuin 2 inhibitor | 0.092 0.005 DBMET00506 | DBMET00506 | |
| 0.034 | 0.665 | 0.116 | Glutamate release inhibitor | 0.116 0.025 DBMET00506 | DBMET00506 | |
| 0.027 | 0.662 | 0.151 | Interferon gamma antagonist | 0.151 0.077 DBMET00506 | DBMET00506 | |
| 0.004 | 0.649 | 0.06 | Prolyl endopeptidase inhibitor | 0.06 0.024 DBMET00506 | DBMET00506 | |
| 0.015 | 0.66 | 0.109 | Protein kinase stimulant | 0.109 0.106 DBMET00506 | DBMET00506 | |
| 0.011 | 0.656 | 0.06 | Transcription factor AP-1 inhibitor | 0.06 0.044 DBMET00506 | DBMET00506 | |
| 0.017 | 0.666 | 0.324 | Aldehyde dehydrogenase inhibitor | 0.324 0.01 DBMET00506 | DBMET00506 | |
| 0.011 | 0.665 | 0.123 | Glucose-6-phosphate translocase inhibitor | 0.123 0.004 DBMET00506 | DBMET00506 | |
| 0.026 | 0.681 | 0.25 | Neurotrophic factor enhancer | 0.25 0.038 DBMET00506 | DBMET00506 | |
| 0.006 | 0.666 | 0.024 | Complement factor 1s inhibitor | 0.024 0.022 DBMET00506 | DBMET00506 | |
| 0.026 | 0.691 | 0.27 | Transcription factor STAT inhibitor | 0.27 0.073 DBMET00506 | DBMET00506 | |
| 0.012 | 0.679 | 0.119 | Acetylcholine M1 receptor antagonist | 0.119 0.11 DBMET00506 | DBMET00506 | |
| 0.013 | 0.683 | 0.121 | Glycine receptor agonist | 0.121 0.012 DBMET00506 | DBMET00506 | |
| 0.019 | 0.693 | 0.228 | Amylase inhibitor | 0.228 0.035 DBMET00506 | DBMET00506 | |
| 0.003 | 0.682 | 0.031 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.031 0.03 DBMET00506 | DBMET00506 | |
| 0.004 | 0.689 | 0.106 | Monophenol monooxygenase inhibitor | 0.106 0.071 DBMET00506 | DBMET00506 | |
| 0.045 | 0.738 | 0.145 | Ca2+-transporting ATPase inhibitor | 0.145 0.056 DBMET00506 | DBMET00506 | |
| 0.011 | 0.709 | 0.122 | Neuropeptide Y1 antagonist | 0.122 0.117 DBMET00506 | DBMET00506 | |
| 0.001 | 0.704 | 0.018 | Telomerase stimulant | 0.018 0.011 DBMET00506 | DBMET00506 | |
| 0.009 | 0.716 | 0.138 | Creatine kinase inhibitor | 0.138 0.03 DBMET00506 | DBMET00506 | |
| 0.002 | 0.713 | 0.065 | Methionyl aminopeptidase 2 inhibitor | 0.065 0.005 DBMET00506 | DBMET00506 | |
| 0.002 | 0.721 | 0.026 | Vanilloid 2 agonist | 0.026 0.016 DBMET00506 | DBMET00506 | |
| 0.009 | 0.73 | 0.188 | Arachidonic acid antagonist | 0.188 0.045 DBMET00506 | DBMET00506 | |
| 0.011 | 0.746 | 0.107 | Anabolic | 0.107 0.053 DBMET00506 | DBMET00506 | |
| 0.01 | 0.753 | 0.095 | MDM2 inhibitor | 0.095 0.009 DBMET00506 | DBMET00506 | |
| 0.062 | 0.809 | 0.184 | ErbB-1 antagonist | 0.184 0.109 DBMET00528 | DBMET00528 | |
| 0.002 | 0.757 | 0.067 | Thromboxane A2 antagonist | 0.067 0.024 DBMET00506 | DBMET00506 | |
| 0.012 | 0.769 | 0.116 | Sphingosine 1-phosphate receptor 4 antagonist | 0.116 0.08 DBMET00506 | DBMET00506 | |
| 0.006 | 0.768 | 0.039 | Phenylethanolamine N methyltransferase inhibitor | 0.039 0.032 DBMET00506 | DBMET00506 | |
| 0.002 | 0.766 | 0.043 | Glycine transporter inhibitor | 0.043 0.038 DBMET00506 | DBMET00506 | |
| 0.002 | 0.771 | 0.063 | Thromboxane antagonist | 0.063 0.03 DBMET00506 | DBMET00506 | |
| 0.012 | 0.783 | 0.541 | Aldehyde oxidase inhibitor | 0.541 0.027 DBMET00506 | DBMET00506 | |
| 0.007 | 0.785 | 0.194 | Hypolipemic | 0.194 0.099 DBMET00506 | DBMET00506 | |
| 0.01 | 0.791 | 0.148 | Sphingosine 1-phosphate receptor 5 antagonist | 0.148 0.065 DBMET00506 | DBMET00506 | |
| 0.013 | 0.814 | 0.124 | NADPH oxidase inhibitor | 0.124 0.077 DBMET00506 | DBMET00506 | |
| 0.005 | 0.807 | 0.117 | Microtubule formation inhibitor | 0.117 0.063 DBMET00506 | DBMET00506 | |
| 0.004 | 0.807 | 0.319 | Anesthetic general | 0.319 0.029 DBMET00506 | DBMET00506 | |
| 0.004 | 0.812 | 0.082 | Cytokine production stimulant | 0.082 0.005 DBMET00506 | DBMET00506 | |
| 0.005 | 0.821 | 0.135 | Cyclooxygenase inhibitor | 0.135 0.083 DBMET00506 | DBMET00506 | |
| 0.035 | 0.853 | 0.35 | 5 Hydroxytryptamine release stimulant | 0.35 0.057 DBMET00506 | DBMET00506 | |
| 0.006 | 0.825 | 0.275 | Non-steroidal antiinflammatory agent | 0.275 0.034 DBMET00506 | DBMET00506 | |
| 0.004 | 0.845 | 0.11 | Alkaline phosphatase inhibitor | 0.11 0.099 DBMET00506 | DBMET00506 | |
| 0.005 | 0.848 | 0.161 | Spasmolytic | 0.161 0.153 DBMET00506 | DBMET00506 | |
| 0.039 | 0.913 | 0.166 | 5 Hydroxytryptamine 3E antagonist | 0.166 0.148 DBMET00506 | DBMET00506 | |
| 0.02 | 0.926 | 0.208 | Calcium channel activator | 0.208 0.201 DBMET00506 | DBMET00506 | |
| 0.004 | 0.926 | 0.115 | Cyclooxygenase 2 inhibitor | 0.115 0.086 DBMET00506 | DBMET00506 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |